Kura Oncology, Inc.KURANASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+84.5%
5Y CAGR+61.9%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+84.5%/yr
vs +11.2%/yr prior
5Y CAGR
+61.9%/yr
Recent acceleration
Acceleration
+73.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
11.1x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$25.26M+19.0%
2024$21.23M+61.2%
2023$13.17M+227.3%
2022$4.03M+408.2%
2021$792000.00-65.2%
2020$2.27M-48.8%
2019$4.44M+68.4%
2018$2.64M+179.5%
2017$943000.00+16.9%
2016$807000.00-